AKR1D1 is down-regulated in patients with type 2 diabetes and we have recently shown asimilar decrease in expression with advancing severity of non-alcoholic fatty liver disease(NAFLD) (Valanejad et al. 2018,Nikolaou et al. 2019b). The gene discussed is AKR1D1; the disease is metabolic dysfunction-associated steatotic liver disease.